Table III.

Random sampling study of RHCE genotyping by ASO-PCR and phenotyping by the haemagglutination test.

	Genotyping					Phenotyping
	C	C	E	e		C	c	E	E
C 1*	P	P	N	P	Ccee	P	P	N	P	Ccee
C 2	P	N	P	P	CCEe	P	N	P	P	CCEe
C 3	P	P	P	P	CcEe	P	P	P	P	CcEe
C 4	P	N	P	P	CCEe	P	N	P	P	CCEe
C 5	P	P	P	P	CcEe	P	P	P	P	CcEe
C 6	N	P	P	N	ccE	N	P	P	N	ccEE
C 7	P	N	P	P	CCEe	P	N	P	P	CCEe
C 8	P	P	P	P	CcEe	N	P	P	P	ccEe
C 9	P		P	N	CCEE	P	N	P	N	CCEE
C 10	P	P	P	N	CceEE	P	P	P	N	CcEE
T1**	P	P	P	P	CcEe	P	N	P	P	CCEe
T2	P	P	P	N	CcEE	P	P	P	P	CcEe
T3	P	P	P	P	CcEe	P	P	P	P	CcEe
T4	P	P	N	P	Ccee	P	P	P	N	CcEE
T5	P	N	P	P	CcEe	P	N	P	N	CCEE
T6	P	P	P	N	CcEE	N	P	N	P	Ccee
T7	P	P	P	P	CcEe	P	P	P	N	CcEE
T8	P	P	N	P	Ccee	P	P	P	P	CcEe
T9	P	P	P	P	CcEe	P	P	P	P	CcEe
T10	P	P	P	N	CcEE	P	P	P	P	CcEe
T11	P	N	P	N	CCEE	P	P	N	P	Ccee
T12	N	P	N	P	Ccee	P	N	P	P	CCEe
T13	P	P	P	N	CcEE	P	P	P	P	CcEe
T14	P	P	P	P	CcEe	N	P	P	P	ccEe
T15	P	P	P	P	CcEe	P	N	P	N	CCEE
T16	P	P	N	P	Ccee	P	P	N	P	Ccee
T17	P	P	P	P	CcEe	P	N	N	P	Ccee
T18	P	P	P	P	CcEe	P	N	P	P	CCEe
T19	P	P	N	P	Ccee	P	P	P	N	CcEE
T20	P	P	P	P	CcEe	P	N	P	P	CCEe
T21	P	P	N	P	Ccee	P	P	P	P	CcEe
T22	P	P	P	P	CcEe	P	N	P	N	CCEE
T23	P	N	P	N	CCEE	P	N	P	N	CCEE
T24	P	P	P	P	CcEe	P	P	P	P	CcEe
T25	P	P	N	P	Ccee	P	P	N	P	Ccee
T26	P	N	P	N	CCEE	P	P	P	P	CcEe
T27	P	P	N	P	Ccee	P	N	P	N	CcEe
T28	P	N	N	P	CCee	P	N	P	P	CCEe
T29	P	N	P	P	CCEe	N	P	P	P	ccEe
T30	P	N	P	N	CCEE	P	P	P	N	CcEE
T31	P	N	P	P	CCEe	P	P	P	P	CcEe
T32	P	P	P	P	CcEe	P	N	N	P	Ccee
T33	N	P	P	P	ccEe	P	P	P	N	CcEE
T34	P	P	P	N	CcEE	P	N	P	P	CCEe
T35	P	N	P	P	CCEe	P	P	P	P	CcEe
T36	P	P	P	P	CcEe	P	N	P	N	CCEE
T37	P	P	N	P	Ccee	P	N	P	P	CCEe
T38	P	N	P	P	CCEe	P	P	P	P	CcEe
T39	P	P	P	P	CcEe	P	P	P	P	CcEe
T40	N	P	P	P	ccEe	P	P	N	P	Ccee

^*C1 to C10: control group;

^**T1 to T40: thalassaemic patients.